Washington: Moderna has started dosing its mRNA-1273 COVID-19 vaccine on children aged six months to less than 12 years.
“We are pleased to begin this Phase 2/3 study of mRNA-1273 on healthy children in the US and Canada and we thank NIAID and BARDA for their collaboration,” said Chief Executive Officer of Moderna Stéphane Bancel.
The trial will involve about 6,750 children in the United States and Canada. Each child will be given two shots, 28 days apart. The dosage will be lower than that for adults.
Moderna’s vaccine is being administered to people over 18 in the US.
Bhubaneswar: A statement reportedly made by Kendrapada Collector Smruti Ranjan Pradhan regarding backwardness in the…
Bhubaneswar: The Odisha Vigilance sleuths on Monday apprehended Dr Ashok Das, consultant O&G (clinical)-cum- Joint…
New Delhi: An image of a gold-coloured Rs 7 coin featuring cricketer Mahendra Singh Dhoni…
Bhubaneswar/Puri: Amid concerns over delay in Ratna Bhandar's repair work even after the end of…
Imphal: The National Investigation Agency (NIA) has taken charge of probing three key cases related…
New Delhi: The once elusive Aamir Khan has become more visible in the past few…
Bhubaneswar: Vigilance officials on Monday unearthed huge assets including two palatial buildings, four plots and…
Bhubaneswar: The 10th National Children’s Literary Festival 2024 at KIIT International School began on a…